Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZ-A for prevention of progression from prediabetes to type 2 diabetes
ChiCTR2200060997Phase 4Completed
- Sponsor
- Beijing An Zhen Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ramulus mori alkaloids in prediabetes (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoints: Fasting blood glucose, Oral glucose tolerance test and 1 more. Started Jan 2022; status: completed.
02
Drugs
ramulus mori alkaloids
03
Conditions
prediabetes
Beyond the preview
Go deeper on ChiCTR2200060997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060997.